{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:44:10Z","timestamp":1773117850329,"version":"3.50.1"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Postchemotherapy surgery for advanced testicular cancer has evolved over the last couple of decades. Patients with nonseminomatous germ cell tumors and residual retroperitoneal mass \u22651 cm should undergo postchemotherapy retroperitoneal lymph node dissection (RPLND). For seminoma, RPLND is considered in those patients with masses \u22653 cm that are also positron emission tomography positive. Masses that occur outside of the retroperitoneum should be completely resected with the possible exception of bilateral lung masses when resection of the first mass shows necrosis. The role of surgery in patients with extragonadal germ cell tumors is most vital in those with primary mediastinal nonseminomatous germ cell tumors. Importantly, patient selection, surgical planning, and consideration of referral to centers with this expertise are important to optimize success.<\/jats:p>","DOI":"10.1634\/theoncologist.2013-0379","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T03:27:26Z","timestamp":1397100446000},"page":"498-506","source":"Crossref","is-referenced-by-count":18,"title":["Postchemotherapy Surgery for Germ Cell Tumors\u2014What Have We Learned in 35 Years?"],"prefix":"10.1093","volume":"19","author":[{"given":"Stephen B.","family":"Riggs","sequence":"first","affiliation":[{"name":"Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina, USA"},{"name":"McKay Department of Urology, Carolinas Healthcare System, Charlotte, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Earl F.","family":"Burgess","sequence":"additional","affiliation":[{"name":"Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris E.","family":"Gaston","sequence":"additional","affiliation":[{"name":"Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina, USA"},{"name":"McKay Department of Urology, Carolinas Healthcare System, Charlotte, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline A.","family":"Merwarth","sequence":"additional","affiliation":[{"name":"Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Raghavan","sequence":"additional","affiliation":[{"name":"Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"2021122308560209400_B1","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1002\/1097-0142(197712)40:6<2987::AID-CNCR2820400634>3.0.CO;2-A","article-title":"The evolution of mature teratoma from malignant testicular tumors","volume":"40","author":"Hong","year":"1977","journal-title":"Cancer"},{"key":"2021122308560209400_B2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jso.2930230403","article-title":"Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapy","volume":"23","author":"Reddel","year":"1983","journal-title":"J Surg Oncol"},{"key":"2021122308560209400_B3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-5347(17)56173-X","article-title":"Cytoreductive surgery for metastatic testis cancer: Considerations of timing and extent","volume":"123","author":"Donohue","year":"1980","journal-title":"J Urol"},{"key":"2021122308560209400_B4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1464-410X.1981.tb03283.x","article-title":"Elective delayed excision of bulky para-aortic lymph node metastases in advanced non-seminoma germ cell tumours of testis","volume":"53","author":"Hendry","year":"1981","journal-title":"Br J Urol"},{"key":"2021122308560209400_B5","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/1097-0142(19810501)47:9<2228::AID-CNCR2820470920>3.0.CO;2-D","article-title":"Combined chemotherapy and surgery in treatment of advanced germ-cell tumors","volume":"47","author":"Vugrin","year":"1981","journal-title":"Cancer"},{"key":"2021122308560209400_B6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-61779-062-1_13","article-title":"PET in testicular cancer","volume":"727","author":"Becherer","year":"2011","journal-title":"Methods Mol Biol"},{"key":"2021122308560209400_B7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2004.07.188","article-title":"2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: An update of the prospective multicentric SEMPET trial","volume":"22","author":"De Santis","year":"2004","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B8","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1200\/JCO.1987.5.7.1064","article-title":"Residual mass: An indication for further therapy in patients with advanced seminoma following systemic chemotherapy","volume":"5","author":"Motzer","year":"1987","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.1996.14.2.454","article-title":"Management of residual mass in advanced seminoma: Results and recommendations from the Memorial Sloan-Kettering Cancer Center","volume":"14","author":"Puc","year":"1996","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-5347(01)65065-1","article-title":"Surgery for a post-chemotherapy residual mass in seminoma","volume":"157","author":"Herr","year":"1997","journal-title":"J Urol"},{"key":"2021122308560209400_B11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejrad.2004.07.012","article-title":"FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals","volume":"54","author":"Becherer","year":"2005","journal-title":"Eur J Radiol"},{"key":"2021122308560209400_B12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-5347(17)52904-3","article-title":"Distribution of nodal metastases in nonseminomatous testis cancer","volume":"128","author":"Donohue","year":"1982","journal-title":"J Urol"},{"key":"2021122308560209400_B13","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1464-410X.2006.06167.x","article-title":"Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: A possible indication for limited dissection","volume":"97","author":"Ehrlich","year":"2006","journal-title":"BJU Int"},{"key":"2021122308560209400_B14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-5347(17)42997-1","article-title":"Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I","volume":"138","author":"Weissbach","year":"1987","journal-title":"J Urol"},{"key":"2021122308560209400_B15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ucl.2011.07.010","article-title":"The role of lymphadenectomy for testicular cancer: Indications, controversies, and complications","volume":"38","author":"Tarin","year":"2011","journal-title":"Urol Clin North Am"},{"key":"2021122308560209400_B16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.urology.2008.08.501","article-title":"Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer","volume":"73","author":"Pettus","year":"2009","journal-title":"Urology"},{"key":"2021122308560209400_B17","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1097\/01.ju.0000060121.33899.4b","article-title":"Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?","volume":"169","author":"Mosharafa","year":"2003","journal-title":"J Urol"},{"key":"2021122308560209400_B18","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1200\/JCO.2003.03.184","article-title":"Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses","volume":"21","author":"Oldenburg","year":"2003","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5347(06)00508-8","article-title":"Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection","volume":"176","author":"Carver","year":"2006","journal-title":"J Urol"},{"key":"2021122308560209400_B20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1200\/JCO.2009.23.0714","article-title":"Long-term follow-up of cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: Is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?","volume":"28","author":"Ehrlich","year":"2010","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/1756287212443170","article-title":"Retroperitoneal lymphadenectomy and resection for testicular cancer: An update on best practice","volume":"4","author":"Heidenreich","year":"2012","journal-title":"Ther Adv Urol"},{"key":"2021122308560209400_B22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2009.23.0755","article-title":"Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery","volume":"28","author":"Kollmannsberger","year":"2010","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B23","first-page":"112","volume-title":"International Consultation on Testicular Cancer","author":"Osanto","year":"2011"},{"issue":"suppl 7","key":"2021122308560209400_B24","first-page":"244a","article-title":"Pathohistological findings in patients with nonseminomatous germ cell tumors (NSGCT) who undergo postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for small tumours","volume":"29","author":"Pfister","year":"2011","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B25","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1200\/JCO.1997.15.4.1455","article-title":"Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors","volume":"15","author":"Debono","year":"1997","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B26","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0022-5347(17)44439-9","article-title":"Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer","volume":"137","author":"Donohue","year":"1987","journal-title":"J Urol"},{"key":"2021122308560209400_B27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00005392-200101000-00021","article-title":"Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer","volume":"165","author":"Vergouwe","year":"2001","journal-title":"J Urol"},{"key":"2021122308560209400_B28","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/01.ju.0000119121.36427.09","article-title":"Prediction of necrosis after chemotherapy of advanced germ cell tumors: Results of a prospective multicenter trial of the German Testicular Cancer Study Group","volume":"171","author":"Albers","year":"2004","journal-title":"J Urol"},{"key":"2021122308560209400_B29","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1995.13.5.1177","article-title":"Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: Multivariate analysis of individual patient data from six study groups","volume":"13","author":"Steyerberg","year":"1995","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B30","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0022-5347(01)67616-X","article-title":"Complications of post-chemotherapy retroperitoneal lymph node dissection","volume":"153","author":"Baniel","year":"1995","journal-title":"J Urol"},{"key":"2021122308560209400_B31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.urolonc.2008.10.026","article-title":"Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer","volume":"28","author":"Subramanian","year":"2010","journal-title":"Urol Oncol"},{"key":"2021122308560209400_B32","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1200\/JCO.2001.19.10.2647","article-title":"Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy\u2014Results from an international study group","volume":"19","author":"Fizazi","year":"2001","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdm472","article-title":"Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): Results of the sCR2 international study","volume":"19","author":"Fizazi","year":"2008","journal-title":"Ann Oncol"},{"key":"2021122308560209400_B34","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1200\/JCO.1993.11.7.1294","article-title":"Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections","volume":"11","author":"Fox","year":"1993","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/A:1008200425854","article-title":"Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors","volume":"8","author":"Hartmann","year":"1997","journal-title":"Ann Oncol"},{"key":"2021122308560209400_B36","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1200\/JCO.1996.14.6.1765","article-title":"Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis","volume":"14","author":"Brenner","year":"1996","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jtcvs.2008.09.032","article-title":"Nonseminomatous germ cell tumors: Assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis","volume":"137","author":"Besse","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2021122308560209400_B38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.hoc.2011.03.012","article-title":"Treatment of brain metastases from germ cell tumors","volume":"25","author":"Oechsle","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"2021122308560209400_B39","volume-title":"NCCN Clinical Practice Guidelines in Oncology. Testicular Cancer. Version 1, 2011"},{"key":"2021122308560209400_B40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bju.12218","article-title":"Bone metastases in germ cell tumours: Lessons learnt from a large retrospective study","volume":"112","author":"Jamal-Hanjani","year":"2013","journal-title":"BJU Int"},{"key":"2021122308560209400_B41","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00432-012-1169-3","article-title":"Bone metastases in germ cell tumor patients","volume":"138","author":"Oechsle","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"2021122308560209400_B42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/CCO.0b013e32835f085d","article-title":"Extragonadal germ cell tumors: Clinical presentation and management","volume":"25","author":"Albany","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"2021122308560209400_B43","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.2002.07.062","article-title":"Extragonadal germ cell tumors of the mediastinum and retroperitoneum: Results from an international analysis","volume":"20","author":"Bokemeyer","year":"2002","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B44","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1200\/JCO.2001.19.3.682","article-title":"Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum","volume":"19","author":"Vuky","year":"2001","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.athoracsur.2007.09.020","article-title":"A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors","volume":"85","author":"Kesler","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2021122308560209400_B46","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cncr.22440","article-title":"Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors","volume":"109","author":"Eggener","year":"2007","journal-title":"Cancer"},{"key":"2021122308560209400_B47","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/cncr.22898","article-title":"Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?","volume":"110","author":"Beck","year":"2007","journal-title":"Cancer"},{"key":"2021122308560209400_B48","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1464-410X.1997.00427.x","article-title":"Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer?","volume":"80","author":"Herr","year":"1997","journal-title":"Br J Urol"},{"key":"2021122308560209400_B49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.eururo.2008.09.027","article-title":"Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: Radical or modified template resection","volume":"55","author":"Heidenreich","year":"2009","journal-title":"Eur Urol"},{"key":"2021122308560209400_B50","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0022-5347(17)37036-2","article-title":"Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors","volume":"148","author":"Wood","year":"1992","journal-title":"J Urol"},{"key":"2021122308560209400_B51","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.juro.2008.06.040","article-title":"Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer","volume":"180","author":"Steiner","year":"2008","journal-title":"J Urol"},{"key":"2021122308560209400_B52","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/iju.12072","article-title":"Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer","volume":"20","author":"Kimura","year":"2013","journal-title":"Int J Urol"},{"key":"2021122308560209400_B53","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.urology.2010.05.020","article-title":"Contemporary lymph node counts during primary retroperitoneal lymph node dissection","volume":"77","author":"Thompson","year":"2011","journal-title":"Urology"},{"key":"2021122308560209400_B54","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1002\/cncr.25266","article-title":"Evaluation of lymph node counts in primary retroperitoneal lymph node dissection","volume":"116","author":"Thompson","year":"2010","journal-title":"Cancer"},{"key":"2021122308560209400_B55","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.eururo.2008.08.022","article-title":"Laparoscopic retroperitoneal lymph node dissection: Does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective","volume":"54","author":"Rassweiler","year":"2008","journal-title":"Eur Urol"},{"key":"2021122308560209400_B56","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/cncr.10440","article-title":"Metastatic nonseminomatous germ cell tumors of the testis: Results of elective and salvage surgery for patients with residual retroperitoneal masses","volume":"94","author":"Hendry","year":"2002","journal-title":"Cancer"},{"key":"2021122308560209400_B57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.eururo.2004.08.012","article-title":"Repeat retroperitoneal lymphadenectomy in advanced testicular cancer","volume":"47","author":"Heidenreich","year":"2005","journal-title":"Eur Urol"},{"key":"2021122308560209400_B58","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0090-4295(03)00579-X","article-title":"Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: Clinical presentation, patterns of recurrence, and outcome","volume":"62","author":"McKiernan","year":"2003","journal-title":"Urology"},{"key":"2021122308560209400_B59","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1343::AID-CNCR18>3.0.CO;2-6","article-title":"Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: A plea for an aggressive surgical approach","volume":"82","author":"Sonneveld","year":"1998","journal-title":"Cancer"},{"key":"2021122308560209400_B60","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/01.ju.0000052372.06901.de","article-title":"Repeat retroperitoneal lymph node dissection for metastatic testis cancer","volume":"169","author":"Sexton","year":"2003","journal-title":"J Urol"},{"key":"2021122308560209400_B61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.urolonc.2005.06.007","article-title":"Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer","volume":"23","author":"Beck","year":"2005","journal-title":"Urol Oncol"},{"key":"2021122308560209400_B62","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1200\/JCO.2005.11.684","article-title":"Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection","volume":"23","author":"Beck","year":"2005","journal-title":"J Clin Oncol"},{"key":"2021122308560209400_B63","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.eururo.2012.08.014","article-title":"Contemporary management of postchemotherapy testis cancer","volume":"62","author":"Daneshmand","year":"2012","journal-title":"Eur Urol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2013-0379","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2013-0379","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/19\/5\/498\/41861407\/oncolo_19_5_498.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/19\/5\/498\/41861407\/oncolo_19_5_498.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T01:43:15Z","timestamp":1640310195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/19\/5\/498\/6399347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,9]]},"references-count":63,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,4,9]]},"published-print":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2013-0379","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,5,1]]},"published":{"date-parts":[[2014,4,9]]}}}